astrazeneca
- Trends
UK Firms, Global Investors Adopt Defensive Strategies In China’s Challenged Markets Even As China’s Leadership Convenes To Strategize Growth Targets And Stimulus Plans For 2024
A recent survey conducted by the British Chamber of Commerce in China shed light on the apprehensions of UK firms…
Read More » - Trends
Merck & Daiichi Sankyo’s $22 Billion Cancer Drug Deal; A Pioneering Partnership in Oncology
Merck & Co. has entered a substantial $22 billion agreement with Daiichi Sankyo, securing the rights to sell three experimental…
Read More » - Trends
AstraZeneca Vaccine: Government Vaccine Advisors Unfortunately Says They Don’t Think The United States Will Use The Vaccine For COVID-19 Illness!
The federal government’s vaccine advisors told that they would not foresee that AstraZeneca vaccine will be used in the United…
Read More » - Trends
Oxford/AstraZeneca jabs effective against severe Covid, new trial in US confirms
A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent…
Read More » - Trends
Several European Countries halt the use of Oxford-AstraZeneca Covid -19 vaccines following complications.
AstraZeneca has been in much news following one controversy after another; in the latest several European Countries have temporarily discontinued…
Read More » - Trends
Overpriced Vaccine? Oxford Coronavirus Vaccine Has Been Priced At Approximately $3 To $4. India’s Serum Institute Has, Meanwhile, Said Oxford Coronavirus Vaccine Will Be Priced At A Maximum Of ₹1,000 For Two Doses
Overpriced Vaccine? Oxford Coronavirus Vaccine Has Been Priced At Approximately $3 To $4. India’s Serum Institute Has, Meanwhile, Said Oxford…
Read More » - Trends
Good News Update: Oxford University Antibody Is Tested To Be Exceptionally Successful For Covid-19
Good News Update: Oxford University Antibody Is Tested To Be Exceptionally Successful For Covid-19 The COVID-19 immunization created by the…
Read More »